Zai Lab
再鼎医药
elsewhere's corpus does not cover Zai Lab. The retrieved materials mention 赜灵生物 (Zai Ling Bio / ZeniFold), an AI-driven drug discovery company that completed a nearly RMB 600 million Series C financing in January 2026 , but this appears to be a distinct entity from Zai Lab. No profile information for Zai Lab is available in the bundle.
AI-generated — may contain errors, please verify.
Zai LabCompany
再鼎医药
渲染中…
Mentioned in 5 articles
Coverage
What Would Qiming Venture Partners Look Like Without Nisa Leung?
Together, we welcome a new era.
暗涌Waves·A Clever Exit Move: Turning 180 Million in Three Years
What "divine" new money-making method?
暗涌Waves·Qiming Venture Partners Raises Record 6.5 Billion RMB; Duane Kuang: Scale Was Not the Goal
2020 was a watershed year.
暗涌Waves·Hongshan Healthcare Investing: 17 Years From the Sidelines to Center Stage
Going earlier and deeper has become a defining feature of Hongshan's healthcare investments.
暗涌Waves·FreeS Fund Report 16: The Truth About Early-Stage Healthcare Investing and China Speed | Frees Fund
Is early-stage healthcare investment really as "high-cost, high-risk, slow-return" as they say?
峰瑞资本·
